Britton Gallagher Life Sciences Insurance Division

Risk Management for Life Sciences Pioneers

From an initial formation through clinical trials and into commercialization, our risk advisors identify and address your ever-changing risk and liability needs as a company in the life sciences sector.

For the past 30 years, Britton Gallagher has served as a trusted risk management and insurance broker for life sciences companies in all stages of development and understand the importance of reaching the final step of your exit.

We have extensive experience in developing innovative insurance solutions for clients in the pharmaceutical, medical device and biotechnology industries. Britton Gallagher serves clients with business operations in countries around the world, coordinating the placement of multiple coverages through our network of global partners. 

Client Spotlight: Ganeden Probiotics

Founded in 1997, Ganeden is at the forefront of probiotic research and product development. It is best known for the GanedenBC30 its patented, FDA GRAS probiotic ingredient found in more than 125 leading food and beverage products around the world. The unique stability of GanedenBC30 allows manufacturers to produce effective probiotic functional foods, beverages and companion animal products. Bill Misconish, Ganeden CFO, discusses the challenges of being a growing business in the life sciences sector, including supply chain capacity issues along with packaging disclosures and regulatory demands. He shares how Britton Gallagher has become a proactive and critical risk management partner, advising on operational and customer issues. The BG team monitors the industry, providing the Ganeden team with updates on trends and keeping up with the company's rapid growth to ensure new ventures or changes are covered.

Industry Tailored Solutions

Britton Gallagher has developed propriety techniques to evaluate exposures unique to each organization, enabling our team to offer innovative insurance programs that address all potential risks and liabilities.

Our contract review and audit process ensures a client’s path to commercialization is clear of unnecessary insurance coverage requirements while protecting assets needed to achieve their growth strategy.

Compliance Consultation

We help our clients understand and navigate through the cumbersome, yet unavoidable regulations to remain compliant with industry and governmental standards.

An experienced team of risk advisors monitor various requirements posed on life sciences companies and will negotiate on their behalf to secure more client-friendly regulations in cases of inappropriate or excessive restrictions.

  • 503A and 503B Compounding Pharmacies 
  • Big Data

  • Biomaterials

  • Diagnostics & Personalized Medicine

  • Healthcare IT

  • Medical Devices & Implants

  • MEMS

  • MIDS

  • Implants

  • Pharmaceuticals

  • Therapeutics

  • Clinical Trials Liability

  • Customized Property Insurance

  • Cyber Liability

  • Directors & Officers

  • Errors & Omissions Liability

  • Excess & Umbrella Liability

  • Explant Coverage

  • General Liability

  • Global Clinical Trials

  • Intellectual Property

  • Product Liability

  • Product Recall

  • Professional Liability

  • Regulatory Interruption

  • Supply Chain Interruption

  • Workers’ Compensation


Get the latest news impacting life sciences companies.

Sign up for our exclusive life sciences risk management newsletter!

Subscribe Now!